Related Experiment Video

Updated: Aug 4, 2026

Isolation, Fixation, and Immunofluorescence Imaging of Mouse Adrenal Glands
08:37

Isolation, Fixation, and Immunofluorescence Imaging of Mouse Adrenal Glands

Published on: October 2, 2018

Developmental expression and regulation of adrenocortical cytochrome P4501B1 in the rat

P B Brake1, M Arai, S As-Sanie

  • 1Center for Environmental Toxicology and Department of Pharmacology, University of Wisconsin Medical School, Madison 53706, USA.

Endocrinology
|March 31, 1999
PubMed

Insights

Adrenal cytochrome P4501B1 (CYP1B1) expression in rats is developmentally suppressed after birth. This suppression is independent of diet or maternal factors and may explain neonatal resistance to toxic polycyclic aromatic hydrocarbons.

Area of Science:

  • Biochemistry
  • Developmental Biology
  • Toxicology

Background:

  • Cytochrome P4501B1 (CYP1B1) is involved in metabolizing polycyclic aromatic hydrocarbons.
  • Neonatal rat adrenals show resistance to the toxic effects of these compounds.
  • Understanding CYP1B1 regulation is crucial for explaining this resistance.

Purpose of the Study:

  • To identify and characterize the expression pattern of a 57-kDa protein in rat adrenocortical microsomes.
  • To investigate the factors influencing the expression of this protein, identified as CYP1B1.
  • To elucidate the developmental regulation of CYP1B1 in the rat adrenal gland.

Main Methods:

  • Western blotting to detect CYP1B1 protein levels.
  • Analysis of CYP1B1 expression at various developmental stages (gestation, postnatal days).
  • Studies involving premature weaning, ACTH stimulation, and primary cell cultures.

Main Results:

  • A 57-kDa protein, identified as CYP1B1, showed increased expression postweaning.
  • CYP1B1 levels were low in early postnatal life, increasing significantly around weaning (postnatal days 17-24).
  • Expression was independent of diet transition and ACTH stimulation, suggesting developmental suppression.

Conclusions:

  • Rat adrenal CYP1B1 exhibits developmental suppression, particularly in early postnatal life.
  • This suppression is not linked to diet, maternal presence, or impaired ACTH signaling.
  • The findings may explain the reduced susceptibility of neonatal rat adrenals to toxic polycyclic aromatic hydrocarbons.

More Related Videos

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

Establishment of Zone-Enriched Primary Cultures from the Mouse Adrenal Cortex07:43

Establishment of Zone-Enriched Primary Cultures from the Mouse Adrenal Cortex

Published on: May 8, 2026

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...